Keraflox Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Keraflox General Information
Description
A drug brand. The brand makes an oral antibiotic containing the active pharmaceutical ingredient Prulifloxacin which is used for the treatment of urinary tract infections and chronic bronchitis.
Contact Information
Corporate Office
- Milan
- Italy
Corporate Office
- Milan
- Italy
Keraflox Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Keraflox Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Keraflox FAQs
-
Where is Keraflox headquartered?
Keraflox is headquartered in Milan, Italy.
-
What industry is Keraflox in?
Keraflox’s primary industry is Buildings and Property.
-
Is Keraflox a private or public company?
Keraflox is a Private company.
-
What is the current valuation of Keraflox?
The current valuation of Keraflox is .
-
What is Keraflox’s current revenue?
The current revenue for Keraflox is .
-
Who are Keraflox’s investors?
Keryos has invested in Keraflox.
-
When was Keraflox acquired?
Keraflox was acquired on 17-Dec-2008.
-
Who acquired Keraflox?
Keraflox was acquired by STADA Arzneimittel.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
